Fact CheckerSign in

NCT04491292Recruiting

Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce

Psychosocial Impact of COVID-19 Pandemic on MD Anderson Workforce

Source: ClinicalTrials.gov · Last updated 22 Jul 2026

Brief summary (registry, in English)

This study investigates the impact of the COVID-19 pandemic on the psychosocial health of employees of MD Anderson Cancer Center. Epidemics have been shown to promote psychological stress among medical staff in high risk areas, which may lead to mental health problems. Assessing how the pandemic is affecting employees may allow for more comprehensive actions to be taken to protect the mental health of employees.

Status (registry)
Recruiting
Study type
Observational
Enrollment
20000 (estimated)
First submitted
28 Jul 2020
Start date
18 May 2020
Primary completion date
30 Apr 2028
Lead sponsor
M.D. Anderson Cancer Center
NCT number
NCT04491292

What you commit to

  • Study type: Observational
  • Planned participants: 20000
  • From 18 May 2020 to the primary completion date, 30 Apr 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

  • MD Anderson employees

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
M D Anderson Cancer Center
Coordinator of this site? Confirm its status
HoustonUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.